E. Goode

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer

Nicolò Matteo Luca Battisti, María Sol Andrés, Karla A. Lee et al. · Breast Cancer Research and Treatment · 2021 · 71 citations

Heart Failure, Breast Oncology, Cardiovascular Disease +6

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

Hamzeh Kayhanian, E. Goode, Francesco Sclafani et al. · Clinical Colorectal Cancer · 2017 · 62 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +8

Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients

Michael Davidson, Catherine Cafferkey, E. Goode et al. · Clinical Colorectal Cancer · 2018 · 33 citations

More Than 500, Esophagus, Esophageal Cancer +9

The cost of ipilimumab toxicity

Nadia Yousaf, Michael Davidson, E. Goode et al. · Melanoma Research · 2015 · 22 citations